Opioid use disorders

Dépendance

2. When can the first take-home dose of methadone or buprenorphine be prescribed?

According to the Collège des médecins du Québec guidelines, the first take-home dose can be prescribed three months after starting methadone treatment or two months after starting buprenorphine treatment (this medication is safer than methadone).

This length of time is given by way of indication only. It is a window that allows the physician or health care team to build a relationship of trust with the user and collect the necessary information.
 

1. I’m a family physician. For the past two years, I’ve been following a user who takes opioids once or twice a week on average. He has to take his dose of methadone in front of a pharmacist four days a week. This user would like to have more take-home do

The main criterion in deciding to allow take-home doses of methadone or buprenorphine is the user’s level of organization. A person who uses is not necessarily disorganized. It’s important to have an overall picture of his situation, which includes:

Teaching clinic for medical residents from across Quebec and clinical mentoring days for practicing physicians

In collaboration with the CIUSSS Centre-Sud-de-l’Île-de-Montréal Family Medicine Unit, CRAN offers a teaching clinic for medical residents from across Quebec. Clinical mentoring days can also be organized for practicing physicians on request. To attend the teaching clinic, which can be tailored to each participant’s needs, contact Mr. Frédéric Venne, assistant to the immediate superior, CRAN, at 514 527-6939 extension 224 or by writing to info.cran@ssss.gouv.qc.ca

CRAN-INSPQ training program “Le traitement des troubles liés à l’utilisation des opioïdes: une approche de collaboration transdisciplinaire” [The treatment of opioid use disorders: a collaborative, transdisciplinary approach; available in French only]

Centre de recherche et d’aide pour narcomanes (CRAN)
Institut national de santé publique du Québec (INSPQ)

This training program is offered by CRAN and the INSPQ to physicians, nurses and psychosocial support workers. Based on the most up-to-date knowledge and best practices, this transdisciplinary training program allows participants to acquire the knowledge and skills they need to improve access to care, coordination and continuity of services for patients.

Next training program:
Date to be determined

Continuing professional development day “Discutons douleur!” [Let’s talk about pain; available in French only]

Collège des médecins du Québec

With its practical, clinical scenario–based approach, this workshop is designed to assist physicians and other health professionals in the assessment and management of patients with chronic non-cancer pain.

Next workshops:

Montreal
February 8, 2017, 13:00 – 16:15, May 3 and June 14, 2017

Support service for professionals for the treatment of opioid addiction – Centre de recherche et d’aide pour narcomanes (CRAN)

We’re here for you. If one of your patients/users has an opioid addiction problem, do not hesitate to contact us:

by telephone

514 527-6939, extension 252 (Montreal)

1 866 726-2343 (outside Montreal)

or by email

info.cran@ssss.gouv.qc.ca

One of CRAN’s specialists will contact you as soon as possible.

A support call is not a medical consultation. The attending physician is responsible for deciding what treatment is appropriate.

Prévenir les intoxications involontaires aux opioïdes : vigilance et surveillance [Preventing unintentional opioid overdose: vigilance and monitoring; available in French only]

Submitted by webmestre_cran on Thu, 02/11/2016 - 21:53

K. Patry and C. St-Arnaud, L’interaction, Ordre des pharmaciens du Québec, Spring 2015, Volume 4, Issue 3, pp. 24–27

This link will take you to an article published in L’interaction, the journal of the Ordre des pharmaciens du Québec. The article contains numerous recommendations regarding opioid use and is a valuable tool for prevention and protection of the public, in particular for the prevention of unintentional opioid overdose.

Que faut-il savoir avant d’entreprendre un service de SuboxoneMD (buprénorphine/naloxone)? [What do pharmacists need to know before providing Suboxone® (buprenorphine/naloxone) services?; available in French only]

Submitted by webmestre_cran on Thu, 02/11/2016 - 21:53

Questions de pratique, L’interaction, Ordre des pharmaciens du Québec, Spring 2015, Volume 4, Issue 3, pp. 28–29

This issue of L’interaction provides information on prescribing requirements for Suboxone® (buprenorphine and naloxone) and a reference to the guidelines on the use of buprenorphine published by the Collège des médecins du Québec and the Ordre des pharmaciens du Québec.

Naloxone (Narcan®) (available in French only)

Submitted by webmestre_cran on Thu, 02/11/2016 - 21:28

The PROFAN project (Prévenir et réduire les overdoses – Former et accéder à la naloxone) [Preventing and reducing overdose – Training on and access to naloxone] teaches peers how to administer naloxone, a drug that has been used for the emergency treatment of opioid overdose for 40 years. The PROFAN project was launched by the peer support association, Méta d’Âme, in collaboration with CRAN and Montreal’s Public Health Branch. For more information, click on the link opposite, then on PROFAN at the top of the page.

Pages